Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Prenetics Global Limited - Class A Ordinary Share (NQ:PRE)

18.35 +0.49 (+2.74%)

Streaming Delayed Price Updated: 3:32 PM EDT, Aug 7, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	41,574
Open	17.86
Bid (Size)	18.29 (100)
Ask (Size)	18.38 (200)
Prev. Close	17.86
Today's Range	17.86 - 18.61
52wk Range	7.175 - 23.63
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Prenetics to Report Q2 2026 Financial Results on August 18, 2026, Live-Stream Earnings Event on Stocktwits, and Announces Upcoming Conference Participation

Today 8:30 EDT

From Prenetics Global Limited

Via GlobeNewswire

Prenetics’ IM8 Secures $1 Billion Growth Financing from General Catalyst’s Customer Value Fund (CVF)

July 14, 2026

From Prenetics Global Limited

Via GlobeNewswire

Performance

YTD	+16.3%	+16.3%
1 Month	+9.3%	+9.3%
3 Month	+15.6%	+15.6%
6 Month	+3.6%	+3.6%
1 Year	+132.9%	+132.9%

More News

Prenetics Announces Record Q1 2026 Results with IM8 Revenue Reaching a Record ~$16.7 Million in May, Implying ~$200 Million in Annualized Recurring Revenue

June 10, 2026

From Prenetics Global Limited

Via GlobeNewswire

Prenetics Appoints Hudson Leogrande, Founder and CEO of Multi-Billion-Dollar DTC Brand Comfrt, to Board of Directors as IM8 Accelerates TikTok and Meta Expansion

June 04, 2026

From Prenetics Global Limited

Via GlobeNewswire

Prenetics Global Ltd. (NASDAQ:PRE) Reports Q4 Revenue Beat and Narrower Loss on IM8 Strength ↗

February 18, 2026

Via Chartmill

Prenetics Announces Jay Shetty as IM8 Global Ambassador and Shareholder in Multi-Year Partnership

May 20, 2026

From Prenetics Global Limited

Via GlobeNewswire

Prenetics (PRE) Q1 2026 Earnings Call Transcript ↗

May 19, 2026

Via The Motley Fool

Prenetics Global Q1 Earnings Call Highlights ↗

May 14, 2026

Via MarketBeat

Prenetics Welcomes Brian J. Rosin as Chief Financial Officer of IM8

May 14, 2026

From Prenetics Global Limited

Via GlobeNewswire

Prenetics Announces Preliminary Record Q1 2026 Results with IM8 Revenue Growing Nearly 6x YoY; Company Raises Full-Year 2026 IM8 Revenue Guidance to $190M–$210M

May 14, 2026

From Prenetics Global Limited

Via GlobeNewswire

Prenetics to Report Q1 2026 Financial Results on May 14, 2026 and Host Earnings Conference Call

May 08, 2026

From Prenetics Global Limited

Via GlobeNewswire

Prenetics’ IM8 Named Exclusive Health Supplements Partner of Inter Miami CF in Multi-Year Partnership

May 07, 2026

From Prenetics Global Limited

Via GlobeNewswire

Prenetics’ IM8 Health Partners with Vitamin Angels to Combat Global Malnutrition, Commits to Impacting 400,000 Mothers and Children in Year One

April 14, 2026

From Prenetics Global Limited

Via GlobeNewswire

Prenetics Announces NBA Champion and Two-Time MVP Giannis Antetokounmpo as IM8 Global Partner and Shareholder in Multi-Year Partnership

April 02, 2026

From Prenetics Global Limited

Via GlobeNewswire

Prenetics' IM8 Partners with Superpower to Personalize the Future of Supplementation

March 24, 2026

From Prenetics Global Limited

Via GlobeNewswire

Prenetics to Participate in the 38th Annual ROTH Conference

March 18, 2026

From Prenetics Global Limited

Via GlobeNewswire

The market is filled with gapping stocks in Friday's session. ↗

March 06, 2026

Via Chartmill

Prenetics Authorizes $40 Million Share Repurchase Program

March 06, 2026

From Prenetics Global Limited

Via GlobeNewswire

Prenetics Executives Execute Second Consecutive Round of Post-Earnings Open Market Share Purchases of $1.3 Million— Cumulative Personal Investment Across Both Rounds Reaches $2.7 Million

March 03, 2026

From Prenetics Global Limited

Via GlobeNewswire

Prenetics Launches IM8 Daily Ultimate Essentials PRO — A Clinical Formula with Two New Flavours

February 23, 2026

From Prenetics Global Limited

Via GlobeNewswire

Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity

February 18, 2026

From Prenetics Global Limited

Via GlobeNewswire

Prenetics Reports Record Q4 and FY 2025 Results: IM8 Achieves $120M ARR¹ in 12 Months, Revenue Surges 480% YoY

February 18, 2026

From Prenetics Global Limited

Via GlobeNewswire

Prenetics Appoints Renowned Longevity Expert and Health-Tech CEO, Dr. Darshan Shah, to Board of Directors

February 17, 2026

From Prenetics Global Limited

Via GlobeNewswire

Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity

February 17, 2026

From Prenetics Global Limited

Via GlobeNewswire

Formula 1 Phenom Ollie Bearman Joins Prenetics’ IM8 Health as Global Ambassador and Shareholder

February 13, 2026

From Prenetics Global Limited

Via GlobeNewswire

Frequently Asked Questions

Is Prenetics Global Limited - Class A Ordinary Share publicly traded?

Yes, Prenetics Global Limited - Class A Ordinary Share is publicly traded.

What exchange does Prenetics Global Limited - Class A Ordinary Share trade on?

Prenetics Global Limited - Class A Ordinary Share trades on the Nasdaq Stock Market

What is the ticker symbol for Prenetics Global Limited - Class A Ordinary Share?

The ticker symbol for Prenetics Global Limited - Class A Ordinary Share is PRE on the Nasdaq Stock Market

What is the current price of Prenetics Global Limited - Class A Ordinary Share?

The current price of Prenetics Global Limited - Class A Ordinary Share is 18.35

When was Prenetics Global Limited - Class A Ordinary Share last traded?

The last trade of Prenetics Global Limited - Class A Ordinary Share was at 08/07/26 03:32 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.